Real-time enrollment status for this triple negative breast cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:49 AM UTC
| NCT Number | NCT06460298 |
| Recruiting Status | Recruiting |
| Condition | Triple Negative Breast Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 51 participants |
| Active Locations | 2 sites in the US |
| Sponsor | ProDa BioTech, LLC |
| Last Updated on CT.gov | August 12, 2025 (Aug 12, 2025) |
As of March 2, 2026: Clinical trial NCT06460298 is currently recruiting participants. This clinical trial study for triple negative breast cancer is actively seeking new participants at 2 locations across the United States. The study is sponsored by ProDa BioTech, LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06460298 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06460298 was last updated Aug 12, 2025 (August 12, 2025). HelloStudys verifies this status automatically.